This contract involves the supply of various medicines as specified in the terms of reference. The buyer is seeking a reliable supplier to provide these medicines to the "Sf. Gheorghe" Recovery Hospital in Botosani, Romania. The total value of the contract is approximately €632,446.57. Suppliers int
Contract awarded. Originally published 10 months ago.
Only 2 prior awards here — too little to read.
In healthcare medical, ST GEORGE RECOVERY HOSPITAL BOTOSANI has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This procurement procedure aims to acquire essential medicines necessary for patient treatment, as their absence significantly increases health risks. The medicines will be procured in the specified forms and quantities outlined in the tender specifications. According to Article 160 of Law No. 98/20
This contract involves the supply of various medicines as specified in the terms of reference. The total value of the contract is approximately €766,428.87. The buyer is the "Sf. Gheorghe" Recovery Hospital in Botosani, Romania. Suppliers are invited to provide the required medicines to meet the hea
This contract is for a framework agreement to supply various food products, including dairy, meat, vegetables, and fruits. Detailed descriptions and quantities of the required products are outlined in the specifications document and the lot list included in this documentation. Please note that the p
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
